The Omega-3 Index is Inversely Associated with the Neutrophil-Lymphocyte Ratio in Adults

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.

The Neutrophil – Lymphocyte Ratio, is an emerging biomarker of systemic inflammation and the innate-adaptive immune system balance that is readily accessible from a complete blood count.